NELTRUZE
Live / Registered — Registered (as of 08 Feb 2022)
What this means for you
Registered since 08 Feb 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90574602
- Registration number
- 6637096
- Mark type
- Stylized text
- Filed
- 11 Mar 2021
- Published for opposition
- 23 Nov 2021
- Registered
- 08 Feb 2022
- Attorney of record
- Sean P. McMahon
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and medicinal preparations and substances for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical preparations and substances for human use for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical preparations and substances for the prevention and treatment of cancer; pharmaceutical compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of tumors; anti-cancer drugs and pharmaceutical preparations
- Class 042 — Scientific and technological services: research and development services in the field of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; biological research; scientific research services; research and development services in the pharmaceutical and biotechnology fields; research services relating to the development and testing of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; testing and inspection of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; product safety and quality testing in the pharmaceutical and biotechnology fields; provision of information and data relating to research and development in the pharmaceutical and biotechnology fields
Owner
- Shorla Pharma Limited, Clonmel, Co. Tipperary, IE
- Shorla Pharma Limited, Clonmel, Co. Tipperary, IE
- Shorla Pharma Limited, Clonmel, Co. Tipperary, IE
Prosecution history
- 25 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Feb 2022 — REGISTERED-PRINCIPAL REGISTER
- 23 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Nov 2021 — PUBLISHED FOR OPPOSITION
- 03 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Oct 2021 — ELECTRONIC RECORD REVIEW COMPLETE
- 08 Oct 2021 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 06 Oct 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Oct 2021 — ASSIGNED TO EXAMINER
- 27 Sept 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Sept 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Sept 2021 — ASSIGNED TO LIE
- 12 Sept 2021 — TEAS VOLUNTARY AMENDMENT RECEIVED